Cargando…
Application of a Novel (68)Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients
BACKGROUND: Breast cancer is a heterogeneous disease, and the human epidermal growth factor receptor 2 (HER2) expression may vary considerably between primary and metastatic lesions, or even within a single lesion. Repeated biopsies cannot always be performed. In this feasibility trial, we assessed...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195516/ https://www.ncbi.nlm.nih.gov/pubmed/35712499 http://dx.doi.org/10.3389/fonc.2022.894767 |